Related Experiment Video
Updated: May 14, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Cell therapy for Parkinson's disease: what next?
Anders Bjorklund1, Jeffrey H Kordower
1Wallenberg Neuroscience Center, Lund University, Sweden. anders.bjorklund@med.lu.se
Summary
Cell transplantation offers a potential Parkinson's disease (PD) therapy by replacing lost dopamine neurons. Current research focuses on developing safe, functional stem cell protocols for clinical use.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Parkinson's disease (PD) involves the progressive loss of midbrain dopamine neurons.
- Cell transplantation strategies for PD date back to the 1970s.
- Human fetal dopamine neuroblast transplantation has been explored in clinical trials.
Purpose of the Study:
- To review the history of cell transplantation in PD animal models.
- To summarize clinical trial experiences with human fetal dopamine neuroblast transplants.
- To discuss challenges and advancements in developing stem cell-based therapies for PD.
Main Methods:
- Review of historical data from animal models of PD.
- Summary of outcomes from open-label and placebo-controlled clinical trials.
- Analysis of current stem cell research for generating dopamine neurons.
Main Results:
- Early cell transplantation efforts in PD models showed promise.
- Clinical trials with fetal neuroblasts provided valuable experience.
- Generating functional and safe dopamine neurons from stem cells remains a key challenge.
Conclusions:
- Stem cell-derived dopamine neuron transplantation is a promising future therapy for Parkinson's disease.
- Standardized, scalable, and GMP-compliant protocols are crucial for clinical translation.
- Continued research aims to overcome challenges for effective cell-based PD treatments.
More Related Videos
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.